The effects of orally administered terbinafine on sebum composition [17]

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 3, 2004, Pages 392-393

  Albanese, G ^a   Marca, S ^b   Camera, E ^c   Picardo, M ^c  

^a CAM Medical Centre   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; CUMENE HYDROPEROXIDE; LEUKOTRIENE; LIPID PEROXIDE; PROSTAGLANDIN; SQUALENE; TERBINAFINE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; CLINICAL ARTICLE; DERMATOMYCOSIS; DRUG EFFICACY; FEMALE; HUMAN; IN VIVO STUDY; INHIBITION KINETICS; LETTER; LIPID PEROXIDATION; MALE; ONYCHOMYCOSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUALITATIVE ANALYSIS; SEBORRHEIC DERMATITIS; SEBUM; TINEA CORPORIS; TINEA CRURIS; TINEA PEDIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; COHORT STUDIES; DERMATOMYCOSES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEBUM; TREATMENT OUTCOME;

EID: 2442581461     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00827.x     Document Type: Letter

References (10)

1. Camera E, Cannistraci C, Briganti S. Scavenging effects of terbinafine on free radicals in vitro. Br J Dermatol 1999; 140: 640-644.
2. Jones TC, Hettler O, Loria Y. Pityrosporum ovale as the causative agent of seborrhoeic dermatitis: new treatment options. Br J Dermatol 1996; 134 (Suppl. 46): 12-15.
3. Passi S, Morrone A, Picardo M, Ippolito F. La patogenesi della dermatite seborroica alla luce dei risultati di una terapia innovativa. G Ital Dermatol Venereol 1992; 127: 1-6.
4. Cassano N, Loconsole F, Mastrolonardo M, Vena GA. Terbinafina orale nella dermatite seborroica: meccanismo d'azione ed esperienze cliniche preliminari. In: Bartoletti CA, editor. Medicina Estetica: Metodologie Diagnostiche, Preventive e Correttive. Editrice Salus Internazionale, 1998: 757-763.
5. Vena GA, Loconsole F, Cassano N. Valutazione dell'efficacia e della tollerabilità della terbinafina orale nella dermatite seborroica. Studio multicentrico calabro-lucano. Ann Ital Dermatol Clin Sper 1999; 53: 1-7.
6. Passi S, Morrone A, De Luca C et al. Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids, lipoperoxides and glutathione peroxidase in patients affected with seborrhoeic dermatitis. J Dermatol Sci 1991; 2: 171-178.
7. Passi S, Picardo M, Morrone A et al. Skin surface lipids in HIV sero-positive and HIV sero-negative patients affected with seborrhoeic dermatitis. J Dermatol Sci 1991; 2: 84-91.
8. Picardo M, Zompetta C, De Luca C. Role of skin surface lipids in UV-induced epidermal cell changes. Arch Dermatol Res 1991; 283: 191-197.
9. Picardo M, Zompetta C, De Luca C. Squalene peroxides may contribute to ultraviolet light-induced immunological effects. Photodermatol Photoimmunol Photomed 1991; 8: 105-110.
10. De Luca C, Picardo M, Breathnach AS, Passi S. Lipooxygenase activity of Pityrosporum: characterisation of by-products and possible role in pityriasis versicolor. Exp Dermatol 1996; 5: 49-56.